Odonate Therapeutics
$33.269876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$33.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.16 (+0.48%) Today
$0.00 (0.00%) As of 4:01 PM EST after-hours
Why Robinhood?
You can buy or sell ODT and other stocks, options, ETFs, and crypto commission-free!
About ODT
Odonate Therapeutics, Inc. Common Stock, also called Odonate Therapeutics, is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. Read More It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA.
Employees
130
Headquarters
San Diego, California
Founded
2013
Market Cap
1.06B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
102.78K
High Today
$33.86
Low Today
$32.70
Open Price
$33.05
Volume
73.50K
52 Week High
$43.75
52 Week Low
$11.54
Collections
ODT Earnings
-$1.24
-$1.09
-$0.94
-$0.79
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
-$1.04 per share
Actual
-$0.88 per share